Which Patients Should Receive Dual Defibrillators? Results of DATAS

  • Aurelio Quesada
  • Mónica Giménez
  • Victor Palanca
  • Javier Jiménez
  • Alfonso Valle
  • José Roda
Conference paper


The dual-chamber (DC) implantable cardioverter defibrillator (ICD) was primarily introduced in the market to add atrial-based pacing for those patients simultaneously affecting by bradycardia and fatal ventricular arrhythmias. Following the successful introduction of the original VVED ICDs, device capabilities were rapidly expanded by the addition of AV discrimination and atrial anti-tachycardia therapies (DDED ICDs). It was suggested that these sophisticated devices would overcome the limitations of the single chamber (SC) devices and that their recommended use would be extended.


Ventricular Pace Atrial Pace Implantable Defibrillator Dual Chamber Atrial Tachyarrhythmia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    The AVID investigators (1997) A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337:1576–1583CrossRefGoogle Scholar
  2. 2.
    Buxton AE, Lee KL, Fisher JD et al (1999) A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341:1882–1890PubMedCrossRefGoogle Scholar
  3. 3.
    Bardy GH, Lee KL, Mark DB et al; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225–237PubMedCrossRefGoogle Scholar
  4. 4.
    The DAVID Investigators (2002) The dual chamber and VVI implantable defibrillator (DAVID) trial. Dual chamber pacing or ventricular backup in patients with an implantable defibrillator. JAMA 288:3115–3123CrossRefGoogle Scholar
  5. 5.
    Quesada A, Almendral J, Arribas F et al (2004) The DATAS rationale and design: a controlled, randomized trial to assess the clinical benefit of dual chamber (DDED) defibrillator. Europace 6:142–150PubMedCrossRefGoogle Scholar
  6. 6.
    Bernstein AD, Camm AJ, Fletcher RD et al (1987) The NASPE/BPEG generic pacemaker code for antibradyarrhythmia and adaptive-rate pacing and antitachyarrhythmia devices. Pacing Clin Electrophysiol 10:794–799PubMedCrossRefGoogle Scholar
  7. 7.
    Pacífico A, Hohnloser S, Williams J et al (1999) Prevention of implantable-defibrillator shocks by treatment with sotalol. N Engl J Med 340:1855–1862PubMedCrossRefGoogle Scholar
  8. 8.
    Joglar JA, Acusta AP, Shusterman NH et al (2001) Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: retrospective analysis of the US Carvedilol Heart Failure Trials Program. Am Heart J 142:498–501PubMedCrossRefGoogle Scholar
  9. 9.
    Moss AJ, Zareba W, Hall WJ et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883PubMedCrossRefGoogle Scholar
  10. 10.
    Melzer C, Ohm M, Bondke HJ et al (2005) Chronotropic incompetence in patients with an implantable cardioverter defibrillator: prevalence and predicting factors. Pacing Clin Electrophysiol 28:1025–1031PubMedCrossRefGoogle Scholar
  11. 11.
    Wolpert C, Jung W, Spehl S et al (2003) Incidence and rate characteristics of atrial tachyarrhythmias in patients with a dual chamber defibrillator. Pacing Clin Electrophysiol 26:1691–1698PubMedCrossRefGoogle Scholar
  12. 12.
    Wong CK, White HD, Wilcox RG et al (2000) New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO III experience. Am Heart J 140:878–885PubMedCrossRefGoogle Scholar
  13. 13.
    Dries DL, Exner DV, Gersh BJ et al (1998) Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 32:695–703PubMedCrossRefGoogle Scholar
  14. 14.
    Denekea T, Lawoa T, Gerritseb B, Lemkea B for the European GEM DR Investigators (2004) Mortality of patients with implanted cardioverter/defibrillators in relation to episodes of atrial fibrillation. Europace 6:151–158CrossRefGoogle Scholar
  15. 15.
    Schoels W, Swerdlow CD, Jung W et al (2001) Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system. The Worldwide Jewel AF Investigators. J Cardiovasc Electrophysiol 12:521–528PubMedCrossRefGoogle Scholar
  16. 16.
    Ricci R, Pignalberi C, Disertori M et al (2002) Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias. Eur Heart J 23:1471PubMedCrossRefGoogle Scholar
  17. 17.
    Friedman PA, Dijkman B, Warman EN et al (2001) Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation 104:1023–1028PubMedCrossRefGoogle Scholar
  18. 18.
    Schwartzman D, Gold M, Quesada A et al for the Worldwide Jewel AF-Only Investigators (2005) Serial evaluation of atrial tachyarrhythmia burden and frequency after implantation of a dual-chamber cardioverter-defibrillator. J Cardiovasc Electrophysiol 16:708–713PubMedCrossRefGoogle Scholar
  19. 19.
    Ricci R, Quesada A, Pignalberi C et al (2004) Dual defibrillator improves quality of life and decreases re-hospitalizations in patients with drug refractory atrial fibrillation. J Interventional Card Electrophysiol 10:85–92CrossRefGoogle Scholar
  20. 20.
    Brugada J, Mont L, Figueiredo M et al (1998) Enhanced detection criteria in implantable defibrillators. J Cardiovasc Electrophysiol 9:261–268PubMedCrossRefGoogle Scholar
  21. 21.
    Kettering K, Dornberger V, Lang R et al (2001) Enhanced detection criteria in implantable cardioverter defibrillators: sensitivity and specificity of the stability algorithm at different heart rates. Pacing Clin Electrophysiol 24:1325–1333PubMedCrossRefGoogle Scholar
  22. 22.
    Deisenhofer I, Kolb Ch, Ndrepepa G et al (2001) Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study. J Cardiovasc Electrophysiol 12:134–142PubMedCrossRefGoogle Scholar
  23. 23.
    Wilkoff B, Gillberg J, De Souza C (2001) The enhanced PR logic dua chamger tachyarrhythmia detection algorithm: retrospective analysis of supraventricular tachycardia with long PR intervals. J Am Coll Cardiol 37(Suppl 2):131A (abs)Google Scholar
  24. 24.
    Dijkman B, Wellens HJ (2000) Importance of the atrial channel for ventricular arrhythmia therapy in the dual chamber implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 11:1309–1319PubMedCrossRefGoogle Scholar
  25. 25.
    Stein KM, Euler DE, Mehra R et al (2002) Do atrial tachyarrhythmias beget ventricular tachyarrhythmias in defibrillator recipients? Jewel AF Worldwide Investigators. J Am Coll Cardiol 40:335–340PubMedCrossRefGoogle Scholar
  26. 26.
    Al-Khatib S, Lucas F, Jollis J et al (2005) The relation between patients’ outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries. J Am Coll Cardiol 46 1536–1540PubMedCrossRefGoogle Scholar
  27. 27.
    Eberhardt F, Bode F, Bonnemeier H et al (2005) Long term complications in single and dual chamber pacing are influenced by surgical experience and patient morbidity. Heart 91:500–506PubMedCrossRefGoogle Scholar
  28. 28.
    Gregoratos G, Cheitlin MD, Conill A et al (1998) ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary — a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). Circulation 97:1325–1335PubMedGoogle Scholar
  29. 29.
    Priori S, Aliot E, Blomstrom-Lundqvist C et al (2001) Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 22:1374–1450PubMedCrossRefGoogle Scholar
  30. 30.
    Friedman PA, McClelland RL, Bamlet WR et al (2006) Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the Detect Supraventricular Tachycardia Study. Circulation 113:2871–2879PubMedCrossRefGoogle Scholar
  31. 31.
    Olshansky B, Day JD, Moore S et al (2007) Is dual-chamber programming inferior to single-chamber programming in an implantable cardioverter-defibrillator? Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) study. Circulation 115:9–16PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2007

Authors and Affiliations

  • Aurelio Quesada
    • 1
  • Mónica Giménez
    • 1
  • Victor Palanca
    • 1
  • Javier Jiménez
    • 1
  • Alfonso Valle
    • 1
  • José Roda
    • 1
  1. 1.Cardiac Electrophysiology and Arrhythmias Section, Department of CardiologyHospital General Universitario de ValenciaValenciaSpain

Personalised recommendations